Calithera Biosciences Patents – Key Insights & Stats

Calithera Biosciences has a total of 476 patents globally, out of which 189 have been granted. Of these 476 patents, more than 64% patents are active. The United States of America is where Calithera Biosciences has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Calithera Biosciences.

Calithera Biosciences was founded in 2010. Calithera Biosciences manufactures pharmaceuticals. For the treatment of cancer, the company is committed to finding and creating new small molecule medications that target tumour metabolism and immunology.

Do read about some of the most popular patents of Calithera Biosciences which have been covered by us in this article and also you can find Calithera Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Calithera Biosciences patent portfolio.

How many patents do the Founder and CEO of Calithera Biosciences have?

The Founder and CEO Susan M. Molineaux have 11 patents.

How many patents does Calithera Biosciences have?

Calithera Biosciences has a total of 476 patents globally. These patents belong to 51 unique patent families. Out of 476 patents, 308 patents are active.

How Many Patents did Calithera Biosciences File Every Year?

Calithera Biosciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCalithera Biosciences Applications FiledCalithera Biosciences Patents Granted
20237
2022638
20212463
20202036
20195419
2018489
20178810
20161093
2015441
201452
2013401
201237
20091

How many Calithera Biosciences patents are Alive/Dead?

Worldwide Patents

Calithera Biosciences Patent Portfolio

How Many Patents did Calithera Biosciences File in Different Countries?

Calithera Biosciences Worldwide Patent Filing

Countries in which Calithera Biosciences Filed Patents

CountryPatent
United States Of America34
Japan27
Europe25
Hong Kong (S.A.R.)24
Singapore22
Israel21
South Africa21
China21
Korea (South)20
Australia19
Mexico16
Brazil15
Canada15
India13
New Zealand11
Germany11
Austria11
Taiwan8
Viet Nam7
Chile7
Malaysia6
Eurasia6
Indonesia6
Philippines6
Spain5
Portugal4
Slovakia4
Croatia4
Hungary4
Poland4
Denmark4
Serbia4
Norway4
Slovenia4
Lithuania4
Malta4
Albania4
Colombia4
Peru3
Argentina3
Costa Rica3
Estonia2
Morocco2
Republic of Moldova2
Macao1
Cyprus1
Italy1
Ukraine1
Former Yugoslav Republic of Macedonia1

Where are Research Centers of Calithera Biosciences Patents Located?

R&D Centres of Calithera Biosciences

10 Best Calithera Biosciences Patents

WO2013078123A1 is the most popular patent in the Calithera Biosciences portfolio. It has received 164 citations so far from companies like Rhizen Pharmaceuticals, Agios Pharmaceuticals, Astrazeneca.

Below is the list of 10 most cited patents of Calithera Biosciences:

Publication NumberCitation Count
WO2013078123A1164
WO2014089048A192
WO2014078645A177
US8604016B248
US20150004134A144
WO2016210106A142
US8865718B232
WO2018049145A132
US20140369961A131
WO2015192014A131

What are Calithera Biosciences key innovation segments?

What Technologies are Covered by Calithera Biosciences?

The chart below distributes patents filed by Calithera Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Calithera Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Calithera Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Calithera Biosciences?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.